Primary |
Drug Use For Unknown Indication |
23.6% |
Product Used For Unknown Indication |
19.3% |
Depression |
16.9% |
Insomnia |
9.4% |
Major Depression |
4.3% |
Sleep Disorder |
3.9% |
Diabetes Mellitus |
3.1% |
Hepatitis C |
2.4% |
Pain |
2.4% |
Anxiety |
2.0% |
Bipolar Disorder |
2.0% |
Fibromyalgia |
2.0% |
Multiple Drug Overdose |
1.6% |
Tachyarrhythmia |
1.6% |
Agitation |
1.2% |
Neuropathy Peripheral |
1.2% |
Back Pain |
0.8% |
Blood Cholesterol Increased |
0.8% |
Dyslipidaemia |
0.8% |
Dyspepsia |
0.8% |
|
Respiratory Arrest |
30.4% |
Serotonin Syndrome |
11.4% |
Drug Toxicity |
6.3% |
Completed Suicide |
5.1% |
Priapism |
5.1% |
Drug Exposure During Pregnancy |
3.8% |
Medication Error |
3.8% |
Pharmaceutical Product Complaint |
3.8% |
Fall |
2.5% |
Hyperhidrosis |
2.5% |
Mental Status Changes |
2.5% |
Metabolic Encephalopathy |
2.5% |
Muscle Spasms |
2.5% |
Myocardial Infarction |
2.5% |
Necrosis |
2.5% |
Premature Baby |
2.5% |
Suicide Attempt |
2.5% |
Tardive Dyskinesia |
2.5% |
Thinking Abnormal |
2.5% |
Thrombocytopenia |
2.5% |
|
Secondary |
Product Used For Unknown Indication |
30.0% |
Drug Use For Unknown Indication |
24.1% |
Depression |
10.2% |
Insomnia |
5.5% |
Anxiety |
5.5% |
Hypertension |
4.0% |
Pain |
3.4% |
Bipolar Disorder |
3.2% |
Mania |
1.9% |
Hallucination, Auditory |
1.8% |
Hallucination, Visual |
1.8% |
Sleep Disorder |
1.3% |
Migraine |
1.1% |
Convulsion |
1.0% |
Foetal Exposure During Pregnancy |
1.0% |
Asthma |
1.0% |
Suicide Attempt |
0.9% |
Drug Abuse |
0.8% |
Back Pain |
0.8% |
Bronchitis |
0.7% |
|
Death |
16.2% |
Cardio-respiratory Arrest |
11.9% |
Completed Suicide |
9.5% |
Overdose |
9.5% |
Tachycardia |
6.2% |
Serotonin Syndrome |
5.7% |
Suicide Attempt |
5.2% |
Somnolence |
4.8% |
Toxicity To Various Agents |
4.8% |
Drug Hypersensitivity |
3.3% |
Drug Exposure During Pregnancy |
2.9% |
Drug Interaction |
2.4% |
Multiple Drug Overdose |
2.4% |
Pyrexia |
2.4% |
Sexual Abuse |
2.4% |
Tremor |
2.4% |
Vomiting |
2.4% |
Pulmonary Congestion |
1.9% |
Respiratory Arrest |
1.9% |
Restless Legs Syndrome |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
23.3% |
Depression |
14.2% |
Drug Use For Unknown Indication |
7.0% |
Pain |
6.0% |
Insomnia |
5.9% |
Anxiety |
4.9% |
Sleep Disorder |
4.8% |
Hypertension |
4.7% |
Bipolar Disorder |
4.4% |
Smoking Cessation Therapy |
4.0% |
Osteoporosis |
3.1% |
Rheumatoid Arthritis |
3.0% |
Arthritis |
2.0% |
Prophylaxis |
2.0% |
Gastrooesophageal Reflux Disease |
2.0% |
Diabetes Mellitus |
1.9% |
Schizophrenia |
1.9% |
Back Pain |
1.8% |
Asthma |
1.6% |
Multiple Myeloma |
1.6% |
|
Vomiting |
12.7% |
Type 2 Diabetes Mellitus |
11.9% |
Nausea |
8.5% |
Weight Increased |
7.9% |
Weight Decreased |
7.7% |
Pain |
5.6% |
Tremor |
4.6% |
Urinary Tract Infection |
4.0% |
Insomnia |
3.9% |
Somnolence |
3.8% |
Suicidal Ideation |
3.5% |
Vision Blurred |
3.5% |
Myocardial Infarction |
3.3% |
Wound Dehiscence |
3.1% |
Headache |
2.8% |
Pain In Extremity |
2.8% |
Drug Ineffective |
2.6% |
Product Quality Issue |
2.6% |
Wheezing |
2.6% |
Death |
2.5% |
|
Interacting |
Schizophrenia |
17.9% |
Product Used For Unknown Indication |
14.9% |
Aggression |
11.9% |
Depression |
9.0% |
Insomnia |
9.0% |
Pain |
7.5% |
Diabetes Mellitus |
6.0% |
Fibromyalgia |
3.0% |
Hypertension |
3.0% |
Paranoia |
3.0% |
Anxiety |
1.5% |
Back Pain |
1.5% |
Bipolar Disorder |
1.5% |
Blood Cholesterol |
1.5% |
Convulsion |
1.5% |
Dementia Alzheimer's Type |
1.5% |
Hypothyroidism |
1.5% |
Neck Pain |
1.5% |
Panic Attack |
1.5% |
Pituitary Tumour Benign |
1.5% |
|
Drug Interaction |
23.8% |
Serotonin Syndrome |
14.3% |
Drug Level Increased |
9.5% |
Pyrexia |
9.5% |
Sedation |
9.5% |
Haemodynamic Instability |
4.8% |
Pain In Extremity |
4.8% |
Panic Attack |
4.8% |
Respiratory Failure |
4.8% |
Somnolence |
4.8% |
Syncope |
4.8% |
White Blood Cell Count Increased |
4.8% |
|